13 May 2015

Hiscox says Q1 "positive period for bonds and equities"

Hiscox, the international specialist insurer, said its investment result to 31 March 2015 was 0.8% on a non-annualised basis. 

In its first quarter interim management statement, the insurer noted that "it has been a positive period for both bonds and equities, particularly following the announcement of quantitative easing by the European Central Bank."

Invested assets totalled about £3.2bn ($5.0bn) at the end of March, excluding third-party assets managed by Kiskadee Investment Managers. In early April about £192m was returned to shareholders. Risk assets now account for approximately 8.5% of the portfolio.

Reporting that gross written premiums increased by 12% to £561.7m (2014: £501.6m) in the first quarter, Hiscox observed that consensus is building that the Federal Reserve will announce its first rate increase since 2006 by the end of this year, "albeit gradually and subject to the data".

"We therefore prefer credit risk to duration risk in our bond portfolios and still expect equities to outperform over the medium term," Hiscox said.

Latest Stories
  • IAR Asia 2025: Hong Kong's RBC is "worryingly" friendly to private market assets, CIO says

    24 June 2025

    And that is worrying for CTF Life CIO, Richard Chan

  • IAR Asia 2025: Being an APAC insurer today is an opportunity, CIOs say

    24 June 2025

    But CIOs' daily worries jump from global recession, to Middle East blowing up, then to a looming GFC

  • IAR Asia 2025: US private credit's exceptionalism may now be limited

    24 June 2025

    Opportunities emerge in Europe, hurdles remain in Asia

  • IAR Asia 2025: Audience pessimistic about most of the world's uncertainties

    24 June 2025

    With some hopes that trade wars will recede

  • Confusion takes over the great normalisation, Guy Miller tells Insurance Asset Risk conference

    23 June 2025

    Summary of Insurance Asset Risk EMEA 2025 keynote by Zurich's Guy Miller

Cookies on Insurance Asset Risk

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here